ConductScience.org, home

Paper19330833

Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?

Näsman A and 16 others. Int J Cancer, 2009. Cited by 578 papers, by iCite.

Cite this record

ConductScience Library. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Papers, record 19330833. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19330833

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?
PubMed
Journal
Int J Cancer
PubMed
Year
2009
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
578
iCite
Relative citation ratio, by iCite
16.9
iCite
Revised in PubMed
2022-04-09
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Näsman AAnders
2Attner PPer
3Hammarstedt LLalle
4Du JJuan
5Eriksson MMathilda
6Giraud GGeraldine
7Ahrlund-Richter SSofie
8Marklund LLinda
9Romanitan MMircea
10Lindquist DDavid
11Ramqvist TTorbjörn
12Lindholm JJohan
13Sparén PPär
14Ye WWeimin
15Dahlstrand HHanna
16Munck-Wikland EEva
17Dalianis TTina

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
PapillomaviridaeMajor topic
Papillomavirus InfectionsMajor topic
Tonsillar NeoplasmsMajor topic
Base Sequence
DNA Primers
Female
Humans
Incidence
Male
Middle Aged
Prevalence
Sweden

Source PubMed

Download CSV of topics

Trials3

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT01358097Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to TherapyBackgroundClinicalTrials.gov
NCT01706939The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx CancerBackgroundClinicalTrials.gov
NCT02945631Quarterback 2b - Sequential Therapy With Reduced Dose Chemoradiotherapy for HPV Oropharynx CancerBackgroundClinicalTrials.gov

Download CSV of trials

Cited by292

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 578 citations.

PMIDTitleJournalYearIn PapersSource
42926887Income-related differences in survival across disease categories in Sweden: a retrospective population-based register study.Lancet Reg Health Eur2026https://conductscience.org/library/papers/42926887PubMed
42769913Promoting expertise knowledge sharing in paediatric virology: An update (Review).Exp Ther Med2026https://conductscience.org/library/papers/42769913PubMed
42471999Dual targeting of PI3K and FGFR or CDK4/6 reveals synergistic responses in HPV-positive and HPV-negative oropharyngeal cancer spheroids.Mol Ther Oncol2026https://conductscience.org/library/papers/42471999PubMed
41910910Inter-rater reliability of MRI Neck Imaging Reporting and Data System (NI-RADS) in the follow-up of oropharyngeal squamous cell carcinoma.Radiol Med2026https://conductscience.org/library/papers/41910910PubMed
41682871Routine Histopreparations After Tonsillectomy, Tonsillotomy, Adenotomy or Conchotomy: A Necessary Diagnosis in Times of Dwindling Resources?J Clin Med2026https://conductscience.org/library/papers/41682871PubMed
41419643Circulating cell free HPVDNA in HPV positive head and neck cancer reveals fast responders and early peakers during treatment.Sci Rep2025https://conductscience.org/library/papers/41419643PubMed
41333028Potential anticancer effects of Peganum harmala in human papillomavirus-related cervical and head and neck cancer cells.Front Pharmacol2025https://conductscience.org/library/papers/41333028PubMed
41158234
Prognostic and predictive roles of circulating microRNAs as biomarkers in head and neck cancer patients in the Northern Territory, Australia undergoing chemoradiotherapy-a pilot prospective cohort study.
Transl Cancer Res2025https://conductscience.org/library/papers/41158234PubMed
41129372Spatial evidence for carcinoma in situ (CIS) as an entity in human papillomavirus (HPV)-associated tonsillar squamous cell carcinoma (TSCC).Int J Cancer2026https://conductscience.org/library/papers/41129372PubMed
40679652Predictive and prognostic value of inflammatory factors (IL-6, IL-8, and TNF-α) in saliva for radiotherapy response in patients with HPV-associated oropharyngeal squamous cell carcinoma.Discov Oncol2025https://conductscience.org/library/papers/40679652PubMed
40490828Prognostic analysis of inconsistent combinations of HPV and p16 in a Chinese/Asian oropharyngeal squamous cell carcinoma population.Infect Agent Cancer2025https://conductscience.org/library/papers/40490828PubMed
40331509Defining the Molecular Intricacies of Human Papillomavirus-Associated Tonsillar Carcinoma.Cancer Control2025https://conductscience.org/library/papers/40331509PubMed
40246777Therapeutic options for human papillomavirus-positive tonsil and base of tongue cancer.J Intern Med2025https://conductscience.org/library/papers/40246777PubMed
39941727Risk Stratification in HPV-Associated Oropharyngeal Cancer: Limitations of Current Approaches and the Search for Better Solutions.Cancers (Basel)2025https://conductscience.org/library/papers/39941727PubMed
39840027A Qualitative Study of Attitudes Toward HPV Vaccine Recommendation in Otolaryngology Clinics.Laryngoscope Investig Otolaryngol2025https://conductscience.org/library/papers/39840027PubMed
39124727Transoral Robotic Surgery and Human Papillomavirus Infection: Impact on Oropharyngeal Cancer Prognosis.J Clin Med2024https://conductscience.org/library/papers/39124727PubMed
38987693
PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trial.
BMC Cancer2024https://conductscience.org/library/papers/38987693PubMed
38920638Moderate SCRIB Expression Levels Correlate with Worse Prognosis in OPSCC Patients Regardless of HPV Status.Cells2024https://conductscience.org/library/papers/38920638PubMed
38918827Immunoreactivity of LMO7 and other molecular markers as potential prognostic factors in oropharyngeal squamous cell carcinoma.BMC Oral Health2024https://conductscience.org/library/papers/38918827PubMed
38440648Association of Human Papillomavirus Infection with Tonsillar Cancers: A Systematic Review.Indian J Otolaryngol Head Neck Surg2024https://conductscience.org/library/papers/38440648PubMed

See all 292 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19330833

GET https://conductscience.org/api/papers/v1/19330833/cited_by?page=2